Related Experiment Video
Updated: Dec 26, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer
Priyanga Selvakumar1, Aja Badgeley1, Paige Murphy1
1Department of Pharmaceutical Sciences, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Abstract:
Breast cancer is a common cancer that occurs due to different epigenetic alterations and genetic mutations. Various epidemiological studies have demonstrated an inverse correlation between breast cancer incidence and flavonoid intake. The anti-cancer action of flavonoids, a class of polyphenolic compounds that are present in plants, as secondary metabolites has been a major topic of research for many years. Our review analysis demonstrates that flavonoids exhibit anti-cancer activity against breast cancer occurring in different ethnic populations. Breast cancer subtype and menopausal status are the key factors in inducing the flavonoid's anti-cancer action in breast cancer. The dose is another key factor, with research showing that approximately 10 mg/day of isoflavones is required to inhibit breast cancer occurrence. In addition, flavonoids also influence the epigenetic machinery in breast cancer, with research demonstrating that epigallocatechin, genistein, and resveratrol all inhibited DNA methyltransferase and altered chromatin modification in breast cancer. These flavonoids can induce the expression of different tumor suppressor genes that may contribute to decreasing breast cancer progression and metastasis. Additional studies are required to confirm the contribution of epigenetic modifications by flavonoids to breast cancer prevention.
Insights
Flavonoids, plant compounds, show anti-cancer effects against breast cancer. Key factors like subtype, menopausal status, and dosage (around 10 mg/day isoflavones) influence their effectiveness, potentially through epigenetic modifications.
Area of Science:
- Oncology
- Nutritional Science
- Epigenetics
Background:
- Breast cancer arises from genetic mutations and epigenetic alterations.
- Epidemiological studies suggest an inverse relationship between flavonoid consumption and breast cancer incidence.
- Flavonoids, plant-derived polyphenolic compounds, are researched for their anti-cancer properties.
Purpose of the Study:
- To review the anti-cancer activity of flavonoids against breast cancer.
- To identify factors influencing flavonoid efficacy in breast cancer.
- To explore the epigenetic mechanisms of flavonoid action in breast cancer.
Main Methods:
- Review of existing epidemiological and experimental studies on flavonoids and breast cancer.
- Analysis of factors such as breast cancer subtype, menopausal status, and dosage.
- Examination of flavonoid-induced epigenetic modifications, including DNA methylation and chromatin remodeling.
Main Results:
- Flavonoids demonstrate anti-cancer activity across diverse ethnic populations with breast cancer.
- Breast cancer subtype and menopausal status significantly modulate flavonoid anti-cancer effects.
- An intake of approximately 10 mg/day of isoflavones may inhibit breast cancer occurrence.
- Specific flavonoids (epigallocatechin, genistein, resveratrol) inhibit DNA methyltransferase and alter chromatin modification.
- Flavonoids can upregulate tumor suppressor genes, potentially reducing breast cancer progression and metastasis.
Conclusions:
- Flavonoids possess significant anti-cancer potential against breast cancer, influenced by host and compound-specific factors.
- Epigenetic modulation, including DNA methylation and chromatin changes, is a key mechanism underlying flavonoid anti-cancer activity.
- Further research is warranted to confirm the role of flavonoid-induced epigenetic modifications in breast cancer prevention.
More Related Videos
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
Cancer Prevention
Some...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Mitogens and the Cell Cycle
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...